Lupa Kata Sandi? Klik di Sini

atau Masuk melalui

Belum Memiliki Akun Daftar di Sini


atau Daftar melalui

Sudah Memiliki Akun Masuk di Sini

Konfirmasi Email

Kami telah mengirimkan link aktivasi melalui email ke rudihamdani@gmail.com.

Klik link aktivasi dan dapatkan akses membaca 2 artikel gratis non Laput di koran dan Majalah Tempo

Jika Anda tidak menerima email,
Kirimkan Lagi Sekarang

Mass COVID-19 Vaccination Program for Aged 12-17

1 July 2021 14:43 WIB

An Indonesian student receives her first dose of China's Sinovac Biotech vaccine for the coronavirus disease (COVID-19) at a high school, as the cases surge in Jakarta, Indonesia, July 1, 2021. The number of Indonesian children contracting the coronavirus has almost tripled since May, with infant deaths from COVID-19 rising sharply as the country suffers its most severe wave of infections so far, a senior paediatrician said on Wednesday. REUTERS/Willy Kurniawan

1 Juli 2021 00:00 WIB

Indonesian students aged 12-17 sit as they wait for their first dose of China's Sinovac Biotech vaccine for the coronavirus disease (COVID-19) at a high school, as the cases surge in Jakarta, Indonesia, July 1, 2021. The percentage of overall cases that were under 18 years of age has risen to 12.6% in June compared to 5% in July last year, according to official data, although Aman noted children were now being tested more. REUTERS/Willy Kurniawan

1 Juli 2021 00:00 WIB

An Indonesian student reacts as he receives his first dose of China's Sinovac Biotech vaccine for the coronavirus disease (COVID-19) at a high school, as the cases surge in Jakarta, Indonesia, July 1, 2021. President Joko Widodo this week announced that authorities had given a green light for children age 12 to 17 to be inoculated with the Sinovac vaccine. REUTERS/Willy Kurniawan

1 Juli 2021 00:00 WIB

Indonesian students aged 12-17 sit as they wait for their first dose of China's Sinovac Biotech vaccine for the coronavirus disease (COVID-19) at a high school, as the cases surge in Jakarta, Indonesia, July 1, 2021. TEMPO/M Taufan Rengganis

1 Juli 2021 00:00 WIB

Indonesian students aged 12-17 sit as they wait for their first dose of China's Sinovac Biotech vaccine for the coronavirus disease (COVID-19) at a high school, as the cases surge in Jakarta, Indonesia, July 1, 2021. TEMPO/M Taufan Rengganis

1 Juli 2021 00:00 WIB

Muhammad Enggar Kurniansyah, a 17-year-old Indonesian student, receives his first dose of China's Sinovac Biotech vaccine for the coronavirus disease (COVID-19) at a high school, as the cases surge in Jakarta, Indonesia, July 1, 2021. REUTERS/Willy Kurniawan

1 Juli 2021 00:00 WIB